QGEN Qiagen Earnings and EPS analysis

?
Relative Growth: Rel. Growth: 61
Relative Strength: Rel. Strength: 20
Relative Valuation: Rel. Valuation: 79
Relative Profitability: Rel. Profitability: 92

EPS in 2026 (TTM): $1.87

Last Report Period Date: Mar 31, 2026

As of June this year, based on Qiagen's most recent financial report, the company's trailing twelve months EPS is $1.87. During 2025, QGEN reported a per-share earnings of $1.96, which shows a rise compared to the EPS of $0.38 recorded in 2024. Qiagen's EPS for the quarterly period ending on Mar 31, 2026 came in at $0.33.

QGEN earnings history

Historical annual and quarterly earnings per share (EPS) data for Qiagen
EPS (TTM)
$1.87
EPS Growth YoY (Quarterly)
-21.4%
EPS (Quarterly)
$0.33
EPS Growth (Quarterly)
-34%

The yearly earnings per share during 2025 was $1.96, a rise of 415.8% compared to $0.38 recorded in 2024. Over the quarter ending Mar 31, 2026, the earnings per share came in at $0.33, reflecting a 21.4% decline compared to the same quarter a year earlier. As of March 2026, the TTM EPS is $1.87. During 2024, the annual earnings per share was $0.38, representing a decrease of 74.7% compared to 2023.

QGEN earnings chart

QGEN EPS growth history

Earnings per share growth rates over time
EPS Growth YoY (Quarterly)
-21.4%
EPS growth YoY
415.8%
EPS growth 3Y avg
1.8%
EPS growth 5Y avg
3.9%

Qiagen has recorded a decline in earnings per share of 21.4% in the past 12 months (YoY, quarterly). During the past three years, QGEN registered an average yearly EPS growth of 1.8%. Qiagen had an average annual EPS growth of 3.9% in the last five years. Over the last decade, QGEN had an average annual earnings per share growth of 12.9%.

QGEN Earnings Waterfall

Breakdown of revenue, profit and net income for Qiagen

QGEN Earnings vs Peers

What are the earnings of QGEN compared to its peers
Stock name Price to Earnings EPS grwoth 1Y EPS grwoth 3Y EPS grwoth 5Y
QGEN Qiagen NV 19.83 415.8% 1.8% 3.9%
TMO Thermo Fisher Scientific Inc 25.49 7.2% 0% 2%
BDX Becton Dickinson & Co 36.34 -0.9% -0.6% 16.2%
GE General Electric Co 43.57 35.8% 447.4% 12.1%
TECH BIO-TECHNE Corp 79.31 -56.1% -35.2% -20.7%

All data is based on quarterly TTM periods, unless otherwise specified.